Blueberry’s Scientific Advisory Board is composed of world class experts in infection, drug delivery and drug discovery. The Scientific Advisory Board is actively involved in developing and reviewing Blueberry’s scientific direction and progress.
Dr Liam Good
Dr Liam Good studied at the University of British Columbia and University of Guelph in Canada and, with an overseas postdoctoral fellowship from NSERC, went on to the University of Copenhagen, Denmark. Liam then moved to the Karolinska Institute, Stockholm, funded by a Swedish Medical Research Council fellowship, where he became an associate professor in the Department of Cell and Molecular Biology. In 2007 Liam became Senior Lecturer at the Department of Pathology and Infectious Diseases, Royal Veterinary College, University of London and coordinates the Infection and Immunity research group. Liam has consulted for a number of biotechnology and pharmaceutical companies. Liam’s scientific interests include RNA biology, antimicrobial mechanisms and cellular delivery technologies.
Sudax read Pharmacy at the University of Nottingham (1990-1993) and registered as a pharmacist with the Royal Pharmaceutical Society of Great Britain, after a pre-registration year in industry and hospital. She then gained her PhD degree from The School of Pharmacy, University of London (1998). She completed a Professional Certificate in Teaching and Learning in Higher Education at the Institute of Education, University of London (2002) and is a Fellow of the Higher Education Academy. Sudax is also a committee member of the Biomolecules and Vaccines focus group of the Academy of Pharmaceutical Sciences, UK. Sudax has a keen interest in ungual (of the nail) drug delivery following topical application in order to improve the topical therapy of nail diseases such as fungal infections. The latter are fairly common but their treatment is far from ideal. Oral therapy has side effects such as liver toxicity, while topical therapy is limited by the low permeability of the nail plate. Her research in this field is focused on characterisation of the nature of the nail plate, physical and chemical enhancers to improve ungual drug permeation, topical drug carriers, and new drug molecules optimised for topical ungual delivery.
Dr Maria Marlow
Dr Maria Marlow is a pharmacist with a PhD in drug delivery and post doctoral experience in tissue engineering. She has over 18 years industrial drug delivery experience and has worked on many different drug delivery options including AstraZeneca’s metered dose inhaler SYMBICORT. In May 2011, she moved back into academia and in Jan 2012 was appointed as an Associate Professor in Formulation Science and Pharmaceutical Materials in the Drug Delivery and Tissue Engineering Group in the School of Pharmacy, University of Nottingham. Her research is focused on developing drug delivery systems or diagnostics that address an unmet clinical need in collaboration with clinicians.